Artificial Intelligence Application of Neurogenic Bowel Training in Patients With Spinal Cord Injury
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 34
- 主要终点
- Change in Neurogenic Bowel Dysfunction (NBD) Score Assessed by the Neurogenic Bowel Dysfunction Scale
研究概览
简要总结
The aim of this study is to evaluate the effectiveness of patient education delivered through an artificial intelligence (AI)-based mobile application in the management of neurogenic bowel dysfunction in individuals with spinal cord injury. Within the scope of the study, it will be examined whether the mobile application reduces neurogenic bowel scores, contributes to maintaining stool scores within the normal range, and improves the quality of life of individuals. Accordingly, the AI-based education model to be developed is expected to facilitate the integration of bowel management practices into daily life, prevent complications, and enhance social participation.
-
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Volunteers who consent to participate.
- •Age over 18 years.
- •Diagnosed with spinal cord injury (SCI).
- •Diagnosed with neurogenic bowel dysfunction (NBD).
- •Not in spinal shock (return of the bulbocavernosus reflex).
- •Having received routine NBD education at the study center within the last month.
排除标准
- •Individuals with mental retardation.
- •Individuals with visual and/or hearing impairments.
- •Individuals with communication problems.
- •Individuals with a history of additional injuries other than SCI (e.g., head trauma, pelvic injury, pelvic surgery).
- •Individuals diagnosed with neurological disorders such as stroke, Parkinson's disease, polyneuropathy, or multiple sclerosis.
- •Individuals with irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD).
- •Individuals diagnosed with gastrointestinal malignancy.
研究组 & 干预措施
Control Group
The control group consisted of participants who only received the hospital's routine NBD education. No additional intervention was provided. The NBD education was delivered by clinical nurses. At the end of the 4th and 12th weeks, the links for the post-tests were sent to the participants in the control group via WhatsApp messages to their phones. After the completion of the study, a link to the mobile application was also provided to the control group via WhatsApp along with an explanatory note.
intervention group
İndividuals in the intervention group will receive the same routine education as the control group. In addition to the routine education, on the day of discharge, a link will be sent to their phones through which the mobile application will be downloaded. Participants will create an account in the mobile application by entering their name, surname, and password. The purpose of installing the mobile application on the day of discharge is to prevent individuals in the control group from becoming aware of the mobile application. After discharge, participants will be followed up during the 4th and 12th weeks.
干预措施: Mobil Application (Other)
结局指标
主要结局
Change in Neurogenic Bowel Dysfunction (NBD) Score Assessed by the Neurogenic Bowel Dysfunction Scale
时间窗: Baseline (Week 0), Week 4, and Week 12
Neurogenic bowel dysfunction will be assessed using the Neurogenic Bowel Dysfunction (NBD) Scale, a validated questionnaire for individuals with spinal cord injury. The scale ranges from 0 to 47 points, with higher scores indicating more severe bowel dysfunction. The outcome measure is the change in total NBD score from baseline (Week 0) to Week 12.
Change in Bowel Care Time Measured in Minutes
时间窗: Baseline (Week 0), Week 4, and Week 12
Bowel care time will be measured as the average time (in minutes) required to complete bowel care management. Time will be self-reported by participants. The outcome measure is the change in bowel care time from baseline (Week 0) to Week 12.
次要结局
- Change in Fecal Incontinence Rate(Baseline (Week 0), Week 4, and Week 12)
研究者
Senem Duman
Lecturer
Saglik Bilimleri Universitesi